373 related articles for article (PubMed ID: 25695629)
1. Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis.
Wu H; Wei L; Fan F; Ji S; Zhang S; Geng J; Hong L; Fan X; Chen Q; Tian J; Jiang M; Sun X; Jin C; Yin ZY; Liu Q; Zhang J; Qin F; Lin KH; Yu JS; Deng X; Wang HR; Zhao B; Johnson RL; Chen L; Zhou D
Nat Commun; 2015 Feb; 6():6239. PubMed ID: 25695629
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis.
Jiang S; Yan C; Fang QC; Shao ML; Zhang YL; Liu Y; Deng YP; Shan B; Liu JQ; Li HT; Yang L; Zhou J; Dai Z; Liu Y; Jia WP
J Biol Chem; 2014 Oct; 289(43):29751-65. PubMed ID: 25170079
[TBL] [Abstract][Full Text] [Related]
3. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.
Kim W; Khan SK; Gvozdenovic-Jeremic J; Kim Y; Dahlman J; Kim H; Park O; Ishitani T; Jho EH; Gao B; Yang Y
J Clin Invest; 2017 Jan; 127(1):137-152. PubMed ID: 27869648
[TBL] [Abstract][Full Text] [Related]
4. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.
Grijalva JL; Huizenga M; Mueller K; Rodriguez S; Brazzo J; Camargo F; Sadri-Vakili G; Vakili K
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G196-204. PubMed ID: 24875096
[TBL] [Abstract][Full Text] [Related]
5. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
Patel SH; Camargo FD; Yimlamai D
Gastroenterology; 2017 Feb; 152(3):533-545. PubMed ID: 28003097
[TBL] [Abstract][Full Text] [Related]
6. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
Wong KF; Liu AM; Hong W; Xu Z; Luk JM
Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
[TBL] [Abstract][Full Text] [Related]
7. In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C.
Asselah T; Bièche I; Mansouri A; Laurendeau I; Cazals-Hatem D; Feldmann G; Bedossa P; Paradis V; Martinot-Peignoux M; Lebrec D; Guichard C; Ogier-Denis E; Vidaud M; Tellier Z; Soumelis V; Marcellin P; Moreau R
J Pathol; 2010 Jul; 221(3):264-74. PubMed ID: 20527020
[TBL] [Abstract][Full Text] [Related]
8. YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29.
Tumaneng K; Schlegelmilch K; Russell RC; Yimlamai D; Basnet H; Mahadevan N; Fitamant J; Bardeesy N; Camargo FD; Guan KL
Nat Cell Biol; 2012 Dec; 14(12):1322-9. PubMed ID: 23143395
[TBL] [Abstract][Full Text] [Related]
9. Bile acids activate YAP to promote liver carcinogenesis.
Anakk S; Bhosale M; Schmidt VA; Johnson RL; Finegold MJ; Moore DD
Cell Rep; 2013 Nov; 5(4):1060-9. PubMed ID: 24268772
[TBL] [Abstract][Full Text] [Related]
10. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.
Lee KP; Lee JH; Kim TS; Kim TH; Park HD; Byun JS; Kim MC; Jeong WI; Calvisi DF; Kim JM; Lim DS
Proc Natl Acad Sci U S A; 2010 May; 107(18):8248-53. PubMed ID: 20404163
[TBL] [Abstract][Full Text] [Related]
11. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
12. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
13. Targeting YAP and Hippo signaling pathway in liver cancer.
Liu AM; Xu MZ; Chen J; Poon RT; Luk JM
Expert Opin Ther Targets; 2010 Aug; 14(8):855-68. PubMed ID: 20545481
[TBL] [Abstract][Full Text] [Related]
14. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
[TBL] [Abstract][Full Text] [Related]
15. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure.
Vandewynckel YP; Laukens D; Devisscher L; Paridaens A; Bogaerts E; Verhelst X; Van den Bussche A; Raevens S; Van Steenkiste C; Van Troys M; Ampe C; Descamps B; Vanhove C; Govaere O; Geerts A; Van Vlierberghe H
Oncotarget; 2015 Sep; 6(29):28011-25. PubMed ID: 26293671
[TBL] [Abstract][Full Text] [Related]
16. NUAK2 is a critical YAP target in liver cancer.
Yuan WC; Pepe-Mooney B; Galli GG; Dill MT; Huang HT; Hao M; Wang Y; Liang H; Calogero RA; Camargo FD
Nat Commun; 2018 Nov; 9(1):4834. PubMed ID: 30446657
[TBL] [Abstract][Full Text] [Related]
17. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
[TBL] [Abstract][Full Text] [Related]
18. The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense.
Wu H; Xiao Y; Zhang S; Ji S; Wei L; Fan F; Geng J; Tian J; Sun X; Qin F; Jin C; Lin J; Yin ZY; Zhang T; Luo L; Li Y; Song S; Lin SC; Deng X; Camargo F; Avruch J; Chen L; Zhou D
Cell Rep; 2013 May; 3(5):1663-77. PubMed ID: 23684612
[TBL] [Abstract][Full Text] [Related]
19. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.
Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA
Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770
[TBL] [Abstract][Full Text] [Related]
20. Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.
Zhang S; Chen Q; Liu Q; Li Y; Sun X; Hong L; Ji S; Liu C; Geng J; Zhang W; Lu Z; Yin ZY; Zeng Y; Lin KH; Wu Q; Li Q; Nakayama K; Nakayama KI; Deng X; Johnson RL; Zhu L; Gao D; Chen L; Zhou D
Cancer Cell; 2017 May; 31(5):669-684.e7. PubMed ID: 28486106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]